glycerinated german cockroach allergenic extract

Allergenexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2007 (NCT00434421)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, desensitized

    Immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • glycerinated german cockroach allergenic extract

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02710136Phase 1Feb 1, 2016Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID)
NCT00829985Phase 1/Phase 2 (Phase 2)Jan 1, 2009Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID)
NCT00434421Phase 1Feb 1, 2007Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID)
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Johns Hopkins UniversityAcademic/Hospital3022007
National Institute of Allergy and Infectious Diseases (NIAID)Government3322007
2 organizations
Page 1 / 1